Company History

The Evolution of Mydecine

Founded in 2020, Mydecine is a biotechnology company developing innovative first- and second-generation novel therapeutics to treat mental health and addiction disorders. Using world-class technology and drug development infrastructure, we are advancing new treatment options in areas of significant unmet need. We see success when all medical and therapy communities view psychedelic medicine as an accepted and adopted form of treatment within our existing healthcare infrastructure.

This is a timeline of the medical, technology, and business accomplishments of Mydecine Innovation Group. This is a timeline of the medical, technology, and business accomplishments of Mydecine Innovation Group.